Search filters

List of works by Mark Geyer

A behavioural and functional neuroimaging investigation into the effects of nicotine on sensorimotor gating in healthy subjects and persons with schizophrenia

scientific article published on 2 February 2006

A comparison of bronchoalveolar lavage versus lung biopsy in pediatric recipients after stem cell transplantation

scientific article

A comparison of immune reconstitution and graft-versus-host disease following myeloablative conditioning versus reduced toxicity conditioning and umbilical cord blood transplantation in paediatric recipients

scientific article

A fMRI investigation of startle gating deficits in schizophrenia patients treated with typical or atypical antipsychotics

scientific article published on 21 August 2006

Adenovirus infection in paediatric allogeneic stem cell transplantation recipients is a major independent factor for significantly increasing the risk of treatment related mortality

scientific article published on 18 October 2011

Analysis of Genetically Regulated Gene Expression Identifies a Prefrontal PTSD Gene, SNRNP35, Specific to Military Cohorts

scientific article published on 01 June 2020

Analysis of Genetically Regulated Gene Expression identifies a trauma type specific PTSD gene, SNRNP35

article

BCMA-Targeted CAR T-cell Therapy plus Radiotherapy for the Treatment of Refractory Myeloma Reveals Potential Synergy

scientific article published on 21 May 2019

BRAF in the cross-hairs

scientific article published on 26 February 2019

Blinatumomab administered concurrently with oral tyrosine kinase inhibitor therapy is a well-tolerated consolidation strategy and eradicates measurable residual disease in adults with Philadelphia chromosome positive acute lymphoblastic leukemia

scientific article published on 23 February 2019

Busulfan, fludarabine, and alemtuzumab conditioning and unrelated cord blood transplantation in children with sickle cell disease.

scientific article published on 9 February 2013

CD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date

scientific article published on 20 May 2016

Concurrent therapy of chronic lymphocytic leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia utilizing CD19-targeted CAR T-cells

scientific article published on 18 October 2017

Cord blood transplantation and stem cell regenerative potential

scientific article

Digging deeper in relapsed acute lymphoblastic leukemia: impact of MRD status on outcome in second remission

scientific article published on 28 July 2017

Enhanced survival during experimental Listeria monocytogenes sepsis in neonatal mice prophylactically treated with Th1 and macrophage immunoregulatory cytokines and mediators

scientific article published in December 2014

Erratum: Genetic loci associated with heart rate variability and their effects on cardiac disease risk

scientific article published on 2 August 2017

First CAR to Pass the Road Test: Tisagenlecleucel's Drive to FDA Approval

scientific article published on 21 November 2018

Genetic loci associated with heart rate variability and their effects on cardiac disease risk

scientific article

Hypofibrinogenemia and disseminated intravascular coagulation rarely complicate treatment-naïve acute lymphoblastic leukemia

scientific article published on 18 May 2020

IgH class switching and translocations use a robust non-classical end-joining pathway

scientific article (publication date: 27 September 2007)

Inotuzumab ozogamicin as chemotherapy-sparing salvage in a 67-year-old man with primary refractory B-cell acute lymphoblastic leukemia with high-risk genomic features

scientific article published on 26 November 2019

Neural correlates of tactile prepulse inhibition: a functional MRI study in normal and schizophrenic subjects

scientific article published in February 2003

Overall survival among older US adults with ALL remains low despite modest improvement since 1980: SEER analysis

scientific article published on 25 January 2017

Pilot trial of risk-adapted cyclophosphamide intensity based conditioning and HLA matched sibling and unrelated cord blood stem cell transplantation in newly diagnosed pediatric and adolescent recipients with acquired severe aplastic anemia

scientific article published on 12 February 2014

Predictors of risk and resilience for posttraumatic stress disorder among ground combat Marines: methods of the Marine Resiliency Study.

scientific article

Prospective assessment of psychophysiological risk factors for PTSD

article

Reduced Toxicity Conditioning and Allogeneic Hematopoietic Progenitor Cell Transplantation for Recessive Dystrophic Epidermolysis Bullosa

scientific article

Reduced toxicity, myeloablative conditioning with BU, fludarabine, alemtuzumab and SCT from sibling donors in children with sickle cell disease

scientific article published on 5 May 2014

Review: Current clinical applications of chimeric antigen receptor (CAR) modified T cells

scientific article

Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: a Children's Oncology Group report

scientific article

Rituximab pharmacokinetics in children and adolescents with de novo intermediate and advanced mature B-cell lymphoma/leukaemia: a Children's Oncology Group report

scientific article published on 27 June 2013

Safety and tolerability of conditioning chemotherapy followed by CD19-targeted CAR T cells for relapsed/refractory CLL.

scientific article published on 2 April 2019

T cell depletion utilizing CD34+ stem cell selection and CD3+ addback from unrelated adult donors in paediatric allogeneic stem cell transplantation recipients

scientific article published on 08 February 2012

The pharmacokinetics and safety of twice daily i.v. BU during conditioning in pediatric allo-SCT recipients

scientific article published on 11 June 2012

The safety and efficacy of clofarabine in combination with high-dose cytarabine and total body irradiation myeloablative conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults (CAYA) with poor-risk acute leuk

scientific article published on 13 June 2018

Tolerability and toxicity of pegaspargase in adults 40 years and older with acute lymphoblastic leukemia

scientific article published on 26 September 2020